drugset / Trial / NCT03035084

Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena?

NCT03035084 ↗

Phase 4 Completed 100 enrolled King Faisal Specialist Hospital & Research Center
RandomizedParallel-groupTriple-blindBasic science

Summary

Several studies have demonstrated that D2 treatment is associated with a decrease in 25(OH)D3 level and therefore have proposed that D3 would be preferable in term of raising total 25(OH)D level. The investigators postulate that the D2 treatment-associated decrease in 25(OH)D3 level may be related to an increase in total 25(OH)D level rather than being specific to D2 treatment, and thus there would be a D3 treatment-associated decrease in 25(OH)D2 level. The investigators plan to conduct a double-blind placebo-controlled trial to examine the effect of D3 treatment on 25(OH)D2 level and the effect of D2 treatment on 25(OH)D3 leve

Timeline

Start
2017-02-15
Primary completion
2017-11-20
Completion
2017-11-20

Outcome

Met primary endpoint

paper in the decrease in day-28 25(OH)D3 (study-1) and 25(OH)D2 (study-2) levels was 13.2 (9.7 to 16.6) and 9.8 (5.2 to 14.4) nmol/L, respectively. PMID 30658603 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 50000 iu Oral
Subject Ergocalciferol Small molecule 50000 iu Oral

Indications